Post by : Shakul

Thailand has announced significant improvements to its universal healthcare system after the National Health Security Office (NHSO) approved higher reimbursement rates for liver and heart transplant procedures. The move is designed to expand access to life-saving treatments and ensure that hospitals can continue providing advanced transplant services to patients across the country.

The decision was made possible through savings generated by adjustments to reimbursement rates for immunosuppressant medications used after organ transplantation. Officials emphasized that the revised drug reimbursement levels reflect lower market prices and will not affect the quality of treatment received by transplant patients. The savings will instead be redirected toward strengthening other areas of transplant care.

Under the new policy, reimbursement for preparing liver donors has been increased substantially. Costs for deceased donor preparation have risen from 30,000 baht to 40,000 baht per person, while support for living donors has increased from 40,000 baht to 45,000 baht. Authorities believe these changes better reflect the actual expenses involved in transplant procedures.

Heart transplant funding has also been revised, with hospitals now receiving a lump-sum reimbursement of 600,000 baht per patient. In addition, reimbursement for pediatric liver transplants has been increased to 660,000 baht per patient, providing greater financial support for highly specialized medical care required by children with severe liver conditions.

For adult liver transplant patients, particularly those suffering from advanced liver disease and cirrhosis, the reimbursement structure has been redesigned. Previously, a single payment covered both donor and recipient procedures. Under the new model, donor liver surgery will receive 200,000 baht while liver transplant surgery for recipients will be reimbursed at 660,000 baht, creating a system that more accurately reflects treatment complexity and hospital costs.

The NHSO has also expanded coverage for complications caused by Cytomegalovirus (CMV), a serious infection that commonly affects patients with weakened immune systems following transplantation. Hospitals can now claim up to 180,000 baht per patient for CMV prevention and treatment, while an additional 40,000 baht reimbursement is available when the virus is detected in the bloodstream.

Government officials described organ transplantation as one of the most critical medical services within the healthcare system. They stated that the reimbursement adjustments are intended not only to improve funding levels but also to strengthen long-term service sustainability, reduce financial burdens on healthcare providers, and ensure fair access to complex and costly treatments for patients covered under Thailand’s universal healthcare programme.

#Thailand News #Policy #Health #Digital healthcare